PL356897A1 - Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu - Google Patents

Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu

Info

Publication number
PL356897A1
PL356897A1 PL02356897A PL35689702A PL356897A1 PL 356897 A1 PL356897 A1 PL 356897A1 PL 02356897 A PL02356897 A PL 02356897A PL 35689702 A PL35689702 A PL 35689702A PL 356897 A1 PL356897 A1 PL 356897A1
Authority
PL
Poland
Prior art keywords
oxide
application
block copolymer
high stability
propylene oxide
Prior art date
Application number
PL02356897A
Other languages
English (en)
Other versions
PL199642B1 (pl
Inventor
Janusz Boratyński
Andrzej Górski
Tomasz Lipiński
Danuta Syper
Beata Weber-Dąbrowska
Original Assignee
Instytut Immunologii i Terapii Doświadczalnej PAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Immunologii i Terapii Doświadczalnej PAN filed Critical Instytut Immunologii i Terapii Doświadczalnej PAN
Priority to PL356897A priority Critical patent/PL199642B1/pl
Priority to PCT/PL2003/000123 priority patent/WO2004045645A2/en
Priority to AU2003286984A priority patent/AU2003286984A1/en
Publication of PL356897A1 publication Critical patent/PL356897A1/pl
Publication of PL199642B1 publication Critical patent/PL199642B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/12011—Details dsRNA Bacteriophages
    • C12N2795/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Zaprezentowano preparaty bakteriofagowe o podwyższonej stabilności oraz nowe zastosowanie blokowych kopolimerów tlenku etylenu i tlenku propylenu do stabilizowania aktywności preparatów bakteriofagowych. Stabilizowane preparaty bakteriofagowe o podwyższonej trwałości znajdują zastosowanie w lecznictwie.
PL356897A 2002-11-15 2002-11-15 Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu PL199642B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL356897A PL199642B1 (pl) 2002-11-15 2002-11-15 Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu
PCT/PL2003/000123 WO2004045645A2 (en) 2002-11-15 2003-11-15 A bacteriophage preparation of enhanced stability by application of a block copolymer of ethylene oxide and propylene oxide
AU2003286984A AU2003286984A1 (en) 2002-11-15 2003-11-15 A bacteriophage preparation of enhanced stability by application of a block copolymer of ethylene oxide and propylene oxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL356897A PL199642B1 (pl) 2002-11-15 2002-11-15 Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu

Publications (2)

Publication Number Publication Date
PL356897A1 true PL356897A1 (pl) 2004-05-17
PL199642B1 PL199642B1 (pl) 2008-10-31

Family

ID=32322590

Family Applications (1)

Application Number Title Priority Date Filing Date
PL356897A PL199642B1 (pl) 2002-11-15 2002-11-15 Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu

Country Status (3)

Country Link
AU (1) AU2003286984A1 (pl)
PL (1) PL199642B1 (pl)
WO (1) WO2004045645A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1812025B1 (en) 2004-11-02 2012-09-05 Chr. Hansen A/S Stabilized bacteriophage formulations
AU2009322175B2 (en) * 2008-12-05 2014-10-09 Takeda Vaccines, Inc. Compositions, methods and uses for inducing viral growth
US9603909B2 (en) 2012-05-29 2017-03-28 Intron Biotechnology, Inc. Composition capable of improving stability of bacteriophage lysin proteins
DK4261274T3 (da) * 2022-04-13 2025-06-23 Merck Patent Gmbh Meroxapoler til cellekultur

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB771653A (en) * 1955-08-31 1957-04-03 Medico Biolog Lab Ltd Stabilized bacteriophages
US5616487A (en) * 1994-09-15 1997-04-01 Aastrom Biosciences, Inc. Stabilized retrovirus compositions
US6322783B1 (en) * 1996-08-26 2001-11-27 Seishi Takahashi Bacteriophages, method for screening same and bactericidal compositions using same, and detection kits using same
WO2000061726A1 (fr) * 1999-04-09 2000-10-19 Aventis Pharma S.A. Composition destinee a la conservation d'adenovirus recombinants infectieux
JP5118798B2 (ja) * 2000-03-07 2013-01-16 メルク・シャープ・エンド・ドーム・コーポレイション アデノウイルス製剤

Also Published As

Publication number Publication date
AU2003286984A1 (en) 2004-06-15
PL199642B1 (pl) 2008-10-31
AU2003286984A8 (en) 2004-06-15
WO2004045645A2 (en) 2004-06-03
WO2004045645A3 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
ATE269321T1 (de) Arzneimittel gegen virale erkrankungen
SE9701162D0 (sv) New use II
DE602004019887D1 (de) Physiologisch wirksames polypeptidkonjugat mit verlängerter in vivo halbwertszeit
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
MY125516A (en) Novel composition based on thiazolidinedione and metformin and use
SG146442A1 (en) Sulphonamide derivatives, their preparation and use as medicaments
SE9900961D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
AR025330A1 (es) Combinacion de sustancias activas con clonidina
BR0209645A (pt) Oxazolo- e furopirimidinas e seu uso como medicamentos
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
TR200401363T4 (tr) DNA viral enfeksiyonlarının tedavisi
AU2002332488A1 (en) R-bambuterol, its preparation and therapeutic uses
ATE417608T1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen
IS7492A (is) Lyfjablöndu uppskriftir, sem innifela melantónín
PL356897A1 (pl) Preparat bakteriofagowy o podwyższonej trwałości oraz zastosowanie blokowego kopolimeru tlenku etylenu i tlenku propylenu
GB0028130D0 (en) Polypeptide and uses thereof
PL368686A1 (pl) Nowe aminobenzofenony
DE60309480D1 (de) Vitamin d-analoge
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen